Manifestaciones cutáneas en contexto del brote actual de enfermedad por coronavirus 2019

Morey-Olivé, Miriam; Espiau, María; Mercadal-Hally, María; Lera-Carballo, Esther; García-Patos, Vicenç

doi:10.1016/j.anpedi.2020.04.013

Cited by 41 publications

(10 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Most of the patients with skin manifestations were middle-aged females, while, patients with chilblain-like lesions were younger (mean age: 40.7 years) and patients with vascular lesions were older individuals (mean age: 72.3 years). These findings are along with other studies about the chilblain-like lesions ( 6 , 19 , 24 , 40 ). Maculopapular lesions were the most common dermatologic presentation of COVID-19 patients that commonly appeared at extremities.…”

Section: Discussionsupporting

confidence: 88%

Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review

et al. 2021

View full text Add to dashboard Cite

Introduction: Until now, there are several reports on cutaneous manifestations in COVID-19 patients. However, the link between skin manifestations and the severity of the disease remains debatable. We conducted a systematic review to evaluate the temporal relationship between different types of skin lesions and the severity of COVID-19.Methods: A systematic search was conducted for relevant studies published between January and July 2020 using Pubmed/Medline, Embase, and Web of knowledge. The following keywords were used: “SARS-CoV-2” or “COVID-19” or “new coronavirus” or “Wuhan Coronavirus” or “coronavirus disease 2019” and “skin disease” or “skin manifestation” or “cutaneous manifestation.”Results: Out of 381 articles, 47 meet the inclusion criteria and a total of 1,847 patients with confirmed COVID-19 were examined. The overall frequency of cutaneous manifestations in COVID-19 patients was 5.95%. The maculopapular rash was the main reported skin involvement (37.3%) commonly occurred in middle-aged females with intermediate severity of the disease. Forty-eight percentage of the patients had a mild, 32% a moderate, and 20% a severe COVID-19 disease. The mild disease was mainly correlated with chilblain-like and urticaria-like lesions and patients with vascular lesions experienced a more severe disease. Seventy-two percentage of patients with chilblain-like lesions improved without any medication. The overall mortality rate was 4.5%. Patients with vascular lesions had the highest mortality rate (18.2%) and patients with urticaria-like lesions had the lowest mortality rate (2.2%).Conclusion: The mere occurrence of skin manifestations in COVID-19 patients is not an indicator for the disease severity, and it highly depends on the type of skin lesions. Chilblain-like and vascular lesions are the ends of a spectrum in which from chilblain-like to vascular lesions, the severity of the disease increases, and the patient's prognosis worsens. Those with vascular lesions should also be considered as high-priority patients for further medical care.

show abstract

Section: Discussionsupporting

confidence: 88%

Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In Spain, with full confinement measures imposed by the national government and coinciding with the pandemic, pediatricians and dermatologists have received, through teledermatology/teleconsultation and social networks, a barrage of diverse images, which have subsequently allowed us to approach some of them by direct physical examination of early and late skin manifestations associated with SARS‐Cov‐2 infection 1‐4 . In particular, acro‐ischemic lesions, similar to chilblain (chilblain‐like), have been highlighted in children and adolescents with little or no symptoms, located at fingers and toes.…”

Section: N = 27mentioning

confidence: 99%

Chilblain‐like lesions in pediatrics dermatological outpatients during the COVID ‐19 outbreak

Garcia‐Lara

Linares‐González

Ródenas‐Herranz

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

In Spain, with full confinement measures and coinciding with the pandemic, pediatricians and dermatologists have received, through teledermatology/teleconsultation and social networks, a barrage of diverse images, which have subsequently allowed us to approach some of them by direct physical examination of early and late skin manifestations associated with SARS-Cov-2 infection. We designed a retrospective, cross-sectional study to evaluate the dermatological care of all those patients under the age of 16 who consulted, in person or telematically, for acral lesions (chilblain-like or erythema multiforme-like) in the context of the Coronavirus disease (COVID-19) pandemic, since 15 March 2020 to 24 April 2020, both included in the health area of the Hospital Universitario San Cecilio de Granada. Of all the patients collected, 18 (66%) were male and the overall mean age was 14.44 years. All lacked a personal history of interest and denied previous episodes of chilblains or Raynaud's phenomenon/disease. The clinic was limited to purpuric lesions located on acral regions distributed on hands and feet. Dermatologists and pediatricians should be aware of the lesions associated with COVID-19 infection and their possible complications. It remains to be identified if there are different dermatological patterns in the pediatric and adult population.

show abstract

“…With regards to the form of contamination of children and adolescents, studies have shown the predominance of family transmission (n=15), followed by community transmission (n=12). When mentioning presence of a pre-existing disease or condition, most did not specify whether participants had any previous morbidity (n=15); in 10 studies, children and adolescents did not have pre-existing illnesses or poor health conditions (12,(16)(17)(19)(20)(21)(22)24,32,36) ; in the other studies, heart failure (11) , prematurity (13) , previous infection by Streptococcus (23) , hydronephrosis and leukemia (18) and liver diseases or changes (33,40) were highlighted. As for the need for hospitalization, most studies (n=24) reported that children and/or adolescents were hospitalized for a period of 1 to 20 days (Chart 3).…”

Section: Resultsmentioning

confidence: 99%

“…Xing et al, (30) 1 -6y Family transmission NS Yes/NS Yin et al, (31) 9y NS NS Yes/NS Chen et al, (32) 7m -17y Travel history and community transmission NS Yes/NS Morey-Olivé et al, (33) 2m e 6y Community transmission Cholestatic liver disease Yes/NS Liu et al, (34) 11m -9y Community transmission NS NS Chacón-Aguilar et al, (35) 26d NS NS Yes/06 Ji et al, (36) 9 e 15y Travel history No Yes/02…”

Section: Age Group Probable Contamination Of the Disease Pre-existing Disease/condition Hospitalization/ Length (Days)mentioning

confidence: 99%

Epidemiological profile of children and adolescents with COVID-19: a scoping review

et al. 2021

View full text Add to dashboard Cite

Objective: to map the epidemiological profile of children and adolescents with COVID-19 in the world literature. Methods: a scoping review systematized by the Joanna Briggs Institute protocol in the PubMed/MEDLINE, CINAHL, Web of Science, Scopus, Science direct and Google Scholar databases. Articles with children and/or adolescents with laboratory diagnosis of COVID-19 were used. Results: thirty-two articles were included in the review. Most children and adolescents were male, with contamination by family transmission. The most frequent clinical manifestations were fever, cough and diarrhea. Ten studies cited pre-existing condition/disease, and hospital length ranged from one to twenty days. Three deaths were reported and no study presented race/color, education and socioeconomic conditions. Conclusion: it was possible to screen the epidemiological profile with information about age group, sex, probable contamination of the disease, clinical manifestations, presence of pre-existing disease/condition, hospitalization and deaths among children and adolescents with COVID-19.

show abstract

Manifestaciones cutáneas en contexto del brote actual de enfermedad por coronavirus 2019

Abstract: comunes de la infancia. Dada la situación actual y las medidas de prevención del contagio en los pacientes con COVID-19, sean confirmados o de sospecha, es de especial importancia conocer esta sintomatología como parte del cuadro clínico de la enfermedad.

Cited by 41 publications

References 4 publications

Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review

Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review

Chilblain‐like lesions in pediatrics dermatological outpatients during the COVID ‐19 outbreak

Epidemiological profile of children and adolescents with COVID-19: a scoping review

Contact Info

Product

Resources

About